PPT-LARC PROVISION Dr Barbara Roucayrol

Blithehale Health Centre Figures for Blithehale Health Centre IUCD insertion SDI insertion SDI removal 2016 51 20 11 2017 74 20 15 2018 until July 25 11 6 Identifying patients. At the Law Offices of Stephen E. Penner, PC, our legal team provides cost-effective, comprehensive representation across a wide range of legal matters. We tailor our representation to each client's needs while remaining conscious of legal costs. With more than 30 years of experience, we have the necessary skills and resources to help you achieve your goals. Long-Acting . Reversible . Contraception . (LARC. ) . A Clinical Update. The information contained in this slide set is designed to aid practitioners in making decisions about appropriate obstetric and gynecologic care. This information should not be construed as dictating an exclusive course of treatment or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to the institution or type of practice. . David Hubacher, PhD. Senior Epidemiologist. FHI. Outline of Talk. Description of long-acting reversible contraception (LARC). Worldwide use of long-acting. Advantages and Disadvantages. Service delivery factors. Remove financial barriers to most effective long-term reversible . methods. Promote LARC use . Provide no-cost . contraception . & make a population . impact:. Teen . pregnancy. Repeat . abortion procedures. Enter Presenter’s Name. Enter Presenter’s Organization. Enter Presentation Date. Objectives. Describe the study design and methods. Review key findings from Pre-CHOICE surveys. Review important findings from CHOICE. The scale-up of an integrated service package for the prevention of HIV and unplanned pregnancy in Zambia. Christine . Mazarire. , . Janeen. Drakes, Katie Fox, Alexandra Hoagland, Ann Lockard, Change . . Lessons from the CHOICE Project. Amna. . Dermish. MD MSc. Associate Medical Director, Planned Parenthood of Greater Texas. Associate Professor . OB/GYN, Dell . Medical School at UT Austin . Contraceptive Method Choice . by US Women, 2012. Unintended Pregnancy in First Year of Contraceptive Use (Typical Use). LARC MOAs. Not Abortifacient. Etonogestrel Implant. Potential Limitations. LARC vs NonLARC Continuation Rates. Beyond the Myth, More Than Just Uterus. Shanda R. Dorff, MD, FAAFP. MN AAP Hot Topics Conference, Friday, May 12, 2017. Disclosure. I have zero actual or potential conflicts of interest with anything related to this topic and/or presentation.. IRENE OCHIN ORPRN QPBRN SNOCAP WREN . Meta-Network Learning And Research Center (Meta-LARC. ). June 18, 2013. NAPRG PBRN Meeting. Bethesda, MD. Workshop Outline. Introductions. AHRQ P30 RFA. ong . A. cting Reversible . C. ontraception Implementation in West . V. irginia. Ally Roy, MD. Instructor. Marshall University School of Medicine. Department of Obstetrics and Gynecology. Learning objectives.  . Jim K. Aizire, MD, MHS, PhD . Johns Hopkins University. 26 July 2018. PEPFAR PROMOTE STUDY . J. Aizire , N. Yende , T. Nematadzira , M.E. Nyati , S. Dadabhai , L. Chinula , C. Nakaye , M. Naidoo , M.G. Fowler , T. Taha , US-PEPFAR PROMOTE Cohort. William M. Sappenfield, MD, MPH, CPH. Director, Florida Perinatal Quality Collaborative. The Chiles Center at the College of Public Health. University of South Florida. 2. Vision. “. All. of Florida’s mothers and infants will have the . subdermal implants are safe and effective yet remain underused in this . population. LARC failure rate is less than 1% and only 4.5% of adolescents choose LARC methods. Purpose . T. his quality improvement project aims to evaluate the effectiveness of an evidence based (EB) educational intervention to improve the LARC use in adolescents among providers in an Obstetrical/Gynecology (OB/GYN) practice..